Resilience Mobile App for Teens and Young Adults With Cancer
This study is testing a mobile app called mPRISM, which is a version of an existing program (PRISM) that teaches skills to help teens and young adults (ages 12-25) cope with stress, set goals, and use mindfulness during cancer treatment. The goal is to see if mPRISM is easy to use, helpful, and if it can improve your quality of life and reduce mental health symptoms like anxiety or depression. You may be able to join if you are 12-25 years old, have been diagnosed with a new cancer within the last year, are receiving chemotherapy or radiation at Seattle Children's Hospital, and can speak/read/write English or Spanish. This study is currently unclear on its recruitment status.
- Study design
- This is an interventional study planning to enroll 80 participants. It will use a waitlist control design, meaning some participants will receive the intervention right away, and others will receive it later.
- What's involved
- Participants will engage in a mobile health psychosocial intervention and interactive interviews. The exact number of visits or duration is not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goals of the study, like how acceptable, appropriate, and feasible the intervention is, will be measured immediately after the intervention. Longer-term follow-up is not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Resilience Mobile App for Teens and Young Adults With Cancer
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Acceptability of interventionimmediately post-intervention
The Acceptability of Intervention Measure (AIM) is a well-validated 4-item scale that measures the perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory. Scale ranges from 4 to 20; higher scores are better.
- Appropriateness of interventionimmediately post-intervention
The Intervention Appropriateness Measure (IAM) is a well-validated 4-item scale that measures the perceived fit, relevance, or compatibility of the innovation or evidence-based practice for a given practice setting, provider, or consumer, and/or perceived fit of the innovation to address a particular issue or problem. Scale ranges from 4 to 20; higher scores are better.
- Feasibility of interventionimmediately post-intervention
The Feasibility of Intervention Measure (FIM) is a well-validated 4-item scale that measures the extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting. Scale ranges from 4 to 20; higher scores are better.